Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
495.00    -4.40 (-0.88%)
Bid:
494.00
Ask:
495.20
Spread: 1.20 (0.243%)
Market Cap: £1.34b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARD

3 Jun 2013 13:18

RNS Number : 1429G
Chemring Group PLC
03 June 2013
 



FOR IMMEDIATE RELEASE 3 JUNE 2013

 

CHEMRING GROUP PLC

NIITEK AWARDED $76 MILLION ADDITIONAL HMDS IDIQ DELIVERY ORDER

 

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiary, Non-Intrusive Inspection Technology, Inc. ("NIITEK"), has been awarded a further delivery order worth $76 million to provide spares for the Husky Mounted Detection System ("HMDS") for the US Army. This delivery order is issued under the $579 million multi-year HMDS Ground Penetrating Radar Indefinite-Delivery/Indefinite-Quantity ("IDIQ") contract that was awarded on 30 April 2012. The period of performance for this contract is through to May 2014.

The NIITEK HMDS is a high-performance Ground Penetrating Radar ("GPR") system which functions on Husky vehicles to provide real-time identification of anti-vehicular landmines and other explosive hazards on main supply routes and open areas such as minefields.

Mark Papworth, Chief Executive of Chemring, commented:

"NIITEK's HMDS delivers a critical capability to US Soldiers and Marines, and coalition allies in protecting them against the threat of improvised explosive devices. We are pleased that these delivery orders enable us to continue our proven support to the US Army, and that NIITEK will continue to deliver critical spares to ensure their fleet is mission ready."

-ENDS-

Chemring Group PLC

Rupert Pittman Director of Communications and Investor Relations

01489 881 880 / rupertp@chemring.co.uk

MHP Communications

Andrew Jaques / James White

0203 128 8100

 

Notes to Editors:

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over 60 countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. NIITEK, a Chemring company since 2008, is the world leader in the design, development and production of Advanced Ground Penetrating Radar ("GPR") systems. NIITEK's Advanced GPR systems are at the leading edge of mine detection technology with over 200 systems successfully being used by US and Coalition forces in Afghanistan.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRNKNDDBBKDAAK
Date   Source Headline
3rd Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20267:02 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim results
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20262:36 pmRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
21st May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20263:46 pmRNSDirector/PDMR Shareholding
19th Mar 202611:00 amRNSHolding(s) in Company
4th Mar 20267:00 amRNSAppointment of non-executive director
2nd Mar 20269:15 amRNSTotal Voting Rights
20th Feb 20262:48 pmRNSResult of AGM
20th Feb 20267:00 amRNSAGM Update
16th Feb 20267:00 amRNSHolding(s) in Company
9th Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSTotal Voting Rights
23rd Jan 20264:41 pmRNSDirector/PDMR Shareholding
12th Jan 20261:35 pmRNSNotice of AGM
2nd Jan 202610:29 amRNSTotal Voting Rights
19th Dec 202511:53 amRNSHolding(s) in Company
19th Dec 202511:53 amRNSHolding(s) in Company
18th Dec 20257:00 amRNSBlock listing Interim Review
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
15th Dec 20258:42 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20253:01 pmRNSAdditional Listing - Replacement
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 202512:41 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:38 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSAdditional Listing
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20254:23 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSResults for the year ended 31 October 2025
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.